NextGen Healthcare Overview
Valuation check: NXGN's ROE is -1.47%, below the Technology sector average of 47.89%.
Get informed when a big investor buys or sells
+ Follow-1.47%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
NextGen Healthcare (NXGN) currently reports a ROE of -1.47%. That is below the Technology sector average of 47.89%. Use the charts on this page to explore NextGen Healthcare's ROE history and peer comparisons.
NextGen Healthcare's ROE of -1.47% is lower than the Technology sector average of 47.89%. That is roughly 103.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but NextGen Healthcare's current -1.47% should be judged against Technology norms (sector average: 47.89%) and against NXGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -1.47%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.89%. From there, open related valuation or income-statement pages for NextGen Healthcare, and consider following NXGN for alerts when major investors trade the stock.
NextGen Healthcare is classified in the Technology sector. On ROE, it currently shows -1.47% versus a sector average near 47.89%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NXGN with unrelated industries.
